Details of the Drug

General Information of Drug (ID: DMG5YRP)

Drug Name

MERS-five-helix bundle

Synonyms

MERS-5HB

Indication

Disease Entry	ICD 11	Status	REF
Middle East Respiratory Syndrome (MERS)	1D64	Preclinical	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Antiviral Agents

Drug Type

Protein/peptide drug

Sequence

GITQQVLSENQKLIANKFNQALGAMQTGFTTTNEAFQKVQDAVNNNAQALSKLASELSNT
FGAISASIGDIIQRLDVLESGGRGGSIPNFGSLTQINTTLLDLTYEMLSLQQVVKALNES
YIDLKELGNYGGSGGSGGGITQQVLSENQKLIANKFNQALGAMQTGFTTTNEAFQKVQDA
VNNNAQALSKLASELSNTFGAISASIGDIIQRLDVLESGGRGGSIPNFGSLTQINTTLLD
LTYEMLSLQQVVKALNESYIDLKELGNYGGSGGSGGGITQQVLSENQKLIANKFNQALGA
MQTGFTTTNEAFQKVQDAVNNNAQALSKLASELSNTFGAISASIGDIIQRLDVLE

Cross-matching ID

TTD ID: D02AUY

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
MERS-CoV spike glycoprotein (S)	TT85VHW	A0A140AYZ5_9BETC	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus. Viruses. 2017 Sep 14;9(9). pii: E255.